Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Frontiers in Human Neuroscience
|
June 13, 2020
Brain Metabolism During A Lower Extremity Voluntary Movement Task in Children With Spastic Cerebral Palsy
Eileen G Fowler, William L Oppenheim, Marcia B Greenberg, et al.
Journal of the National Cancer Institute
|
January 25, 2018
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R Kesler, Andrew J Saykin, et al.
Plos One
|
March 14, 2014
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia
Natalie L Rasgon, Cheri L Geist, Heather A Kenna, et al.
Psychiatry Research
|
May 14, 2014
Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy
Natalie L Rasgon, Heather A Kenna, Tonita E Wroolie, et al.
Journal of Clinical and Experimental Neuropsychology
|
July 2, 2025
Neuroimaging studies of cognitive dysfunction following cancer and treatment
Daniel H S Silverman, Charlotte Sleurs, Rebeca A Gavrila Laic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy
Wei Chen, Daniel H S Silverman, Sibylle Delaloye, et al.
Molecular Imaging and Biology
|
October 11, 2003
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment
Daniel H S Silverman, Jeffrey L Cummings, Gary W Small, et al.
Psychoneuroendocrinology
|
September 3, 2010
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
Daniel H S Silverman, Cheri L Geist, Heather A Kenna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2006
Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET
Wei-Ann Hsueh, Amanda L Kesner, Anne Gangloff, et al.
Molecular Imaging and Biology
|
November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
Martin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Frontiers in Human Neuroscience
|
June 13, 2020
Brain Metabolism During A Lower Extremity Voluntary Movement Task in Children With Spastic Cerebral Palsy
Eileen G Fowler, William L Oppenheim, Marcia B Greenberg, et al.
Journal of the National Cancer Institute
|
January 25, 2018
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R Kesler, Andrew J Saykin, et al.
Plos One
|
March 14, 2014
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia
Natalie L Rasgon, Cheri L Geist, Heather A Kenna, et al.
Psychiatry Research
|
May 14, 2014
Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy
Natalie L Rasgon, Heather A Kenna, Tonita E Wroolie, et al.
Journal of Clinical and Experimental Neuropsychology
|
July 2, 2025
Neuroimaging studies of cognitive dysfunction following cancer and treatment
Daniel H S Silverman, Charlotte Sleurs, Rebeca A Gavrila Laic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 3, 2006
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy
Wei Chen, Daniel H S Silverman, Sibylle Delaloye, et al.
Molecular Imaging and Biology
|
October 11, 2003
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment
Daniel H S Silverman, Jeffrey L Cummings, Gary W Small, et al.
Psychoneuroendocrinology
|
September 3, 2010
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
Daniel H S Silverman, Cheri L Geist, Heather A Kenna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2006
Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET
Wei-Ann Hsueh, Amanda L Kesner, Anne Gangloff, et al.
Molecular Imaging and Biology
|
November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
Martin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Page
of 6